Return On Equity of Telomir Pharmaceuticals, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Telomir Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Telomir Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -567%, a 47% increase year-over-year.
  • Telomir Pharmaceuticals, Inc. annual Return On Equity for 2024 was -1154%, a 99% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Telomir Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -567% +511% +47% 01 Jul 2025 30 Sep 2025
Q2 2025 -4594% -3866% -531% 01 Apr 2025 30 Jun 2025
Q1 2025 -1953% -1351% -224% 01 Jan 2025 31 Mar 2025
Q4 2024 -1154% -573% -99% 01 Oct 2024 31 Dec 2024
Q3 2024 -1077% 01 Jul 2024 30 Sep 2024
Q2 2024 -728% 01 Apr 2024 30 Jun 2024
Q1 2024 -602% 01 Jan 2024 31 Mar 2024
Q4 2023 -581% 01 Oct 2023 31 Dec 2023

Telomir Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1154% -573% -99% 01 Jan 2024 31 Dec 2024
2023 -581% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.